USPTO trademark

CTI BIOPHARMA

RegisteredUSPTOWord and designClass 42

"CTI BIOPHARMA" is a word and design mark owned by Cti Biopharma Corp., filed at the USPTO on August 6, 2014. It is registered and covers class 42 (Computer and Scientific Services).

Official USPTO record
CTI BIOPHARMA trademark as filed
As filed with the USPTO
Status
Registered
Since September 30, 2021
Filed
August 6, 2014
Registered
June 14, 2016
Expires
Not recorded
Application no.
86978798
Registration no.
4980005
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns CTI BIOPHARMA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Cti Biopharma Corp.

Seattle, United States

89 trademarks in the portfolioView company

Representative

Frances M. Jagla

Christensen O'Connor Johnson Kindness PLLC

Goods and services

What the mark covers

The products and services CTI BIOPHARMA is filed for, grouped by Nice class.

  • Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; pharmaceutical research and development; providing technical consultation in the field of pharmaceutical product research and development; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  2. Notice of acceptance of sec. 8 & 15 - e-mailed
  3. Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  4. Case assigned to post registration paralegal
  5. Teas section 8 & 15 received
  6. Courtesy reminder - sec. 8 (6-yr) e-mailed
  7. Review of correspondence complete - address updated
  8. Applicant/correspondence changes (non-responsive) entered
  9. Teas change of correspondence received
  10. Attorney/dom.rep.revoked and/or appointed

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About CTI BIOPHARMA

Who owns the trademark "CTI BIOPHARMA"?

The USPTO trademark "CTI BIOPHARMA" (application 86978798) is owned by Cti Biopharma Corp.

What is the status of "CTI BIOPHARMA"?

Its status at the USPTO is: registered.

When was "CTI BIOPHARMA" registered?

It was registered on June 14, 2016.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CTI BIOPHARMA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2902-3d6e-7408-a62a-c9594ad1c735
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2902-3d6e-7408-a62a-c9594ad1c735",
  "object": "trademark",
  "mark_text": "CTI BIOPHARMA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "86978798",
  "filing_date": "2014-08-06",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "CTI BIOPHARMA CORP.",
      "entity_id": "ent_019ebbb1-a963-70ce-a073-2bf07526f153"
    }
  ]
}